Lucile Blaise - 17 Aug 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
President, Sleep & RC Business
Signature
Lucile Blaise, President, Sleep & Respiratory Care
Issuer symbol
RMD
Transactions as of
17 Aug 2023
Net transactions value
$0
Form type
4
Filing time
18 Aug 2023, 13:08:11 UTC
Previous filing
22 Nov 2022
Next filing
29 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Award $0 +819 +12% $0.000000 7,441 17 Aug 2023 Direct F1
transaction RMD ResMed Common Stock Award $0 +3,294 +44% $0.000000 10,735 17 Aug 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on August 17, 2023, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.
F2 Represents performance-based restricted stock units granted on July 1, 2022. The shares were earned on August 17, 2023, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.